3 Small-Cap Stocks That Could Be Big-Time Winners
Think small. It's one of the best ideas for investors seeking to reap returns that trounce the overall market.
Three Motley Fool contributors identified small-cap stocks that they think could especially become big-time winners. Here's why they chose Bluebird Bio (NASDAQ: BLUE), Travere Therapeutics (NASDAQ: TVTX), and Viking Therapeutics (NASDAQ: VKTX).
Prosper Junior Bakiny (Bluebird Bio): Bluebird Bio is a gene-editing specialist currently sporting a market cap of $402 million, putting it squarely in small-cap territory. The biotech has encountered a series of clinical and regulatory setbacks over the past three years, leading to it losing nearly 90% of its value. Yet, there could be some hope for the company.
Source Fool.com
Viking Therapeutics Inc Stock
€59.18
-0.030%
Viking Therapeutics Inc is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 110 € there is a hugely positive potential of 85.87% for Viking Therapeutics Inc compared to the current price of 59.18 €.
